Funded Tech Companies
NextCure
Headquartered in New Haven, NextCure has funding from Ikarian Capital, Squadron Capital and private investors.
Company Overview
Company Name
NextCure
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
9000 Virginia Manor Rd. 200
New Haven, CT 20705
USA
New Haven, CT 20705
USA
Phone
Website
Email Address
Company Background Information
Overview
NextCure (Nasdaq: NXTC), launched in 2015, is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs. The Company is applying its proprietary platforms and know-how to identify novel and biologically relevant targets and develop first-in-class immunotherapy products.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
11/17/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Richman
Chief Financial Officer
Steven Cobourn
Vice President
Linda Liu
VP - Bus. Development
James Bingham
VP - Bus. Development
Sebastien Maloveste
VP - Bus. Development
Timothy Mayer
VP - Regulatory Affairs
Sol Langermann
Company Investors
- Ikarian Capital
- Squadron Capital
- Affinity Asset Advisors
- Pfizer Venture Investments
- Taiho Ventures
- Lilly Asia Ventures
- Ping An Group
- Alexandria Venture Investments
- OrbiMed
- NS Investment
- Hillhouse Capital Group
- Bay City Capital
- Canaan Partners
- Quan Capital
- Sofinnova Ventures
- ArrowMark Partners
- Surveyor Capital
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs